Percutaneous Coronary Interventions and Antiplatelet Therapy in the Perioperative Period

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 21, Issue 3, 2007, Pages 436-442

  Mauermann, William J ^a   Rehfeldt, Kent H ^a   Bell, Malcolm R ^a   Lowson, Stuart M ^b  

^a Mayo Clinic   (United States)

^b UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

anesthesia; antiplatelet aggregates; percutaneous coronary interventions; stent thrombosis; surgery

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; EPTIFIBATIDE; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; METAL; PACLITAXEL; PYRIDINE DERIVATIVE; RAPAMYCIN; THIENOPYRIDINE DERIVATIVE; TICLOPIDINE; TIROFIBAN; UNCLASSIFIED DRUG;

ANTICOAGULANT THERAPY; CLINICAL TRIAL; COMPARATIVE STUDY; CORONARY ARTERY DISEASE; CORONARY STENT; DRUG ELUTING STENT; DRUG HALF LIFE; DRUG MECHANISM; DRUG WITHDRAWAL; HUMAN; IN-STENT RESTENOSIS; MEDICAL DECISION MAKING; NEUTROPENIA; PERCUTANEOUS CORONARY INTERVENTION; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; REVIEW; THROMBOTIC THROMBOCYTOPENIC PURPURA; TREATMENT RESPONSE;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY STENOSIS; CORONARY THROMBOSIS; DECISION MAKING; HUMANS; PERIOPERATIVE CARE; PLATELET AGGREGATION INHIBITORS; STENTS;

EID: 34249686075     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jvca.2007.02.005     Document Type: Review

References (66)

1. Thom T., Haase N., Rosamond W., et al. Heart disease and stroke statistics-2006 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 113 (2006) e85-e151
2. Oesterle S.N., Whitbourn R., Fitzgerald P.J., et al., Stanford Stent Summit faculty. The stent decade: 1987 to 1997. Am Heart J 136 (1998) 578-599
3. Knight C.J., Curzen N.P., Groves P.H., et al. Stent implantation reduces restenosis in patients with suboptimal results following coronary angioplasty. Eur Heart J 20 (1999) 1783-1790
4. Stone G.W., Brodie B.R., Griffin J.J., et al. Clinical and angiographic follow-up after primary stenting in acute myocardial infarction: The Primary Angioplasty in Myocardial Infarction (PAMI) stent pilot trial. Circulation 99 (1999) 1548-1554
5. Serruys P.W., Strauss B.H., Beatt K.J., et al. Angiographic follow-up after placement of a self-expanding coronary artery stent. N Engl J Med 324 (1991) 13-17
6. Fischman D.L., Leon M.B., Baim D.S., et al., Stent Restenosis Study Investigators. A randomized comparison of coronary stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med 331 (1994) 496-501
7. Hearn J.A., King III S.B., Douglas Jr. J.S., et al. Clinical and angiographic outcomes after coronary artery stenting for acute or threatened closure after percutaneous transluminal coronary angioplasty. Initial results with a balloon-expandable, stainless steel design. Circulation 88 (1993) 2086-2096
8. Roubin G.S., Cannon A.D., Agrawal S.K., et al. Intracoronary stenting for acute and threatened closure complicating percutaneous transluminal coronary angioplasty. Circulation 85 (1992) 916-927
9. Serruys P.W., de Jaegere P., Kiemeneij F., et al., Benestent Study Group. A comparison of balloon-expandable stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med 331 (1994) 489-495
10. Ong A.T., Hoye A., Aoki J., et al. Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation. J Am Coll Cardiol 45 (2005) 947-953
11. Moses J.W., Leon M.B., Popma J.J., et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349 (2003) 1315-1323
12. Bhatia V., Bhatia R., and Dhindsa M. Drug-eluting stents: New era and new concerns. Postgrad Med J 80 (2004) 13-18
13. Serruys P.W., Kutryk M.J., and Ong A.T. Coronary artery stents. N Engl J Med 354 (2006) 483-495
14. Kereiakes D.J., Kuntz R.E., Mauri L., et al. Surrogates, substudies, and real clinical endpoints in trials of drug-eluting stents. J Am Coll Cardiol 45 (2005) 1206-1212
15. Stone G.W., Ellis S.G., Cox D.A., et al. One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: The TAXUS-IV trial. Circulation 109 (2004) 1942-1947
16. Babapulle M.N., Joseph L., Belisle P., et al. A hierarchical Bayesian meta-analysis of randomised clinical trials of drug-eluting stents. Lancet 364 (2004) 583-591
17. Iakovou I., Schmidt T., Bonizzoni E., et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 293 (2005) 2126-2130
18. Schouten O., van Domburg R.T., Bax J.J., et al. Noncardiac surgery after coronary stenting: Early surgery and interruption of antiplatelet therapy are associated with an increase in major adverse cardiac events. J Am Coll Cardiol 49 (2007) 122-124
19. McFadden E.P., Stabile E., Regar E., et al. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet 364 (2004) 1519-1521
20. Ong A.T., McFadden E.P., Regar E., et al. Late angiographic stent thrombosis (LAST) events with drug-eluting stents. J Am Coll Cardiol 45 (2005) 2088-2092
21. Rodriguez A.E., Mieres J., Fernandez-Pereira C., et al. Coronary stent thrombosis in the current drug-eluting stent era: Insights from the ERACI III trial. J Am Coll Cardiol 47 (2006) 205-207
22. Stabile E., Cheneau E., Kinnaird T., et al. Late thrombosis in cypher stents after the discontinuation of antiplatelet therapy. Cardiovasc Radiat Med 5 (2004) 173-176
23. Waters R.E., Kandzari D.E., Phillips H.R., et al. Late thrombosis following treatment of in-stent restenosis with drug-eluting stents after discontinuation of antiplatelet therapy. Catheter Cardiovasc Interv 65 (2005) 520-524
24. Karvouni E., Korovesis S., and Katritsis D.G. Very late thrombosis after implantation of sirolimus-eluting stent. Heart 91 (2005) e45
25. Kerner A., Gruberg L., Kapeliovich M., et al. Late stent thrombosis after implantation of a sirolimus-eluting stent. Catheter Cardiovasc Interv 60 (2003) 505-508
26. Joner M., Finn A.V., Farb A., et al. Pathology of drug-eluting stents in humans: Delayed healing and late thrombotic risk. J Am Coll Cardiol 48 (2006) 193-202
27. Guagliumi G., Farb A., Musumeci G., et al. Images in cardiovascular medicine. Sirolimus-eluting stent implanted in human coronary artery for 16 months: pathological findings. Circulation 107 (2003) 1340-1341
28. Kotani J., Awata M., Nanto S., et al. Incomplete neointimal coverage of sirolimus-eluting stents: Angioscopic findings. J Am Coll Cardiol 47 (2006) 2108-2111
29. Cutlip D.E., Baim D.S., Ho K.K., et al. Stent thrombosis in the modern era: A pooled analysis of multicenter coronary stent clinical trials. Circulation 103 (2001) 1967-1971
30. Hasdai D., Garratt K.N., Holmes Jr. D.R., et al. Coronary angioplasty and intracoronary thrombolysis are of limited efficacy in resolving early intracoronary stent thrombosis. J Am Coll Cardiol 28 (1996) 361-367
31. Mehta S.R., and Yusuf S. Short- and long-term oral antiplatelet therapy in acute coronary syndromes and percutaneous coronary intervention. J Am Coll Cardiol 41 (2003) 79S-88S
32. Bossavy J.P., Thalamas C., Sagnard L., et al. A double-blind randomized comparison of combined aspirin and ticlopidine therapy versus aspirin or ticlopidine alone on experimental arterial thrombogenesis in humans. Blood 92 (1998) 1518-1525
33. Yusuf S., Zhao F., Mehta S.R., et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 345 (2001) 494-502
34. Leon M.B., Baim D.S., Popma J.J., et al., Stent Anticoagulation Restenosis Study Investigators. A clinical trial comparing three antithrombotic-drug regimens after coronary artery stenting. N Engl J Med 339 (1998) 1665-1671
35. Smith Jr. S.C., Feldman T.E., Hirshfeld Jr. J.W., et al. ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention-Summary Article A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). J Am Coll Cardiol 47 (2006) 216-235
36. Hongo R.H., Ley J., Dick S.E., et al. The effect of clopidogrel in combination with aspirin when given before coronary artery bypass grafting. J Am Coll Cardiol 40 (2002) 231-237
37. Gill S., Majumdar S., Brown N.E., et al. Ticlopidine-associated pancytopenia: Implications of an acetylsalicylic acid alternative. Can J Cardiol 13 (1997) 909-913
38. Page Y., Tardy B., Zeni F., et al. Thrombotic thrombocytopenic purpura related to ticlopidine. Lancet 337 (1991) 774-776
39. Bertrand M.E., Rupprecht H.J., Urban P., et al. Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting: The clopidogrel aspirin stent international cooperative study (CLASSICS). Circulation 102 (2000) 624-629
40. Muller C., Buttner H.J., Petersen J., et al. A randomized comparison of clopidogrel and aspirin versus ticlopidine and aspirin after the placement of coronary artery stents. Circulation 101 (2000) 590-593
41. Taniuchi M., Kurz H.I., and Lasala J.M. Randomized comparison of ticlopidine and clopidogrel after intracoronary stent implantation in a broad patient population. Circulation 104 (2001) 539-543
42. Nguyen T.A., Diodati J.G., and Pharand C. Resistance to clopidogrel: A review of the evidence. J Am Coll Cardiol 45 (2005) 1157-1164
43. Costa M.A., Sabate M., van der Giessen W.J., et al. Late coronary occlusion after intracoronary brachytherapy. Circulation 100 (1999) 789-792
44. Kaluza G.L., Joseph J., Lee J.R., et al. Catastrophic outcomes of noncardiac surgery soon after coronary stenting. J Am Coll Cardiol 35 (2000) 1288-1294
45. Wilson S.H., Fasseas P., Orford J.L., et al. Clinical outcome of patients undergoing noncardiac surgery in the two months following coronary stenting. J Am Coll Cardiol 42 (2003) 234-240
46. Reddy P.R., and Vaitkus P.T. Risks of noncardiac surgery after coronary stenting. Am J Cardiol 95 (2005) 755-757
47. Sharma A.K., Ajani A.E., Hamwi S.M., et al. Major noncardiac surgery following coronary stenting: When is it safe to operate?. Catheter Cardiovasc Interv 63 (2004) 141-145
48. Vicenzi M.N., Meislitzer T., Heitzinger B., et al. Coronary artery stenting and noncardiac surgery-A prospective outcome study. Br J Anaesth 96 (2006) 686-693
49. Mehta S.R., Yusuf S., Peters R.J., et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: The PCI-CURE study. Lancet 358 (2001) 527-533
50. Steinhubl S.R., Berger P.B., Mann III J.T., et al. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: A randomized controlled trial. JAMA 288 (2002) 2411-2420
51. Eisenstein E.L., Anstrom K.J., Kong D.F., et al. Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. JAMA 297 (2007) 159-168
52. Tuman K.J., McCarthy R.J., O'Connor C.J., et al. Aspirin does not increase allogeneic blood transfusion in reoperative coronary artery surgery. Anesth Analg 83 (1996) 1178-1184
53. Herbert J.M., Dol F., Bernat A., et al. The antiaggregating and antithrombotic activity of clopidogrel is potentiated by aspirin in several experimental models in the rabbit. Thromb Haemost 80 (1998) 512-518
54. Yende S., and Wunderink R.G. Effect of clopidogrel on bleeding after coronary artery bypass surgery. Crit Care Med 29 (2001) 2271-2275
55. Mitka M. Results of CURE trial for acute coronary syndrome. JAMA 285 (2001) 1828-1829
56. Horlocker T.T., Wedel D.J., Benzon H., et al. Regional anesthesia in the anticoagulated patient: Defining the risks (the second ASRA Consensus Conference on Neuraxial Anesthesia and Anticoagulation). Reg Anesth Pain Med 28 (2003) 172-197
57. Kuchulakanti P.K., Chu W.W., Torguson R., et al. Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents. Circulation 113 (2006) 1108-1113
58. Charbucinska K.N., Godet G., Itani O., et al. Anticoagulation management for patients with drug-eluting stents undergoing vascular surgery. Anesth Analg 103 (2006) 261-263
59. Batchelor W.B., Mahaffey K.W., Berger P.B., et al. A randomized, placebo-controlled trial of enoxaparin after high-risk coronary stenting: The ATLAST trial. J Am Coll Cardiol 38 (2001) 1608-1613
60. Berger P.B., Mahaffey K.W., Meier S.J., et al. Safety and efficacy of only 2 weeks of ticlopidine therapy in patients at increased risk of coronary stent thrombosis: Results from the Antiplatelet Therapy alone versus Lovenox plus Antiplatelet therapy in patients at increased risk of Stent Thrombosis (ATLAST) trial. Am Heart J 143 (2002) 841-846
61. Broad L., Lee T., Conroy M., et al. Successful management of patients with a drug-eluting coronary stent presenting for elective, noncardiac surgery. Br J Anaesth 98 (2007) 19-22
62. Fleisher L.A., Beckman J.A., Brown K.A., et al. ACC/AHA 2006 guideline update on perioperative cardiovascular evaluation for noncardiac surgery: Focused update on perioperative beta-blocker therapy: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery) developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society for Vascular Medicine and Biology. J Am Coll Cardiol 47 (2006) 2343-2355
63. Godet G., Riou B., Bertrand M., et al. Does preoperative coronary angioplasty improve perioperative cardiac outcome?. Anesthesiology 102 (2005) 739-746
64. McFalls E.O., Ward H.B., Moritz T.E., et al. Coronary artery revascularization before elective major vascular surgery. N Engl J Med 351 (2004) 2795-2804
65. Brilakis E.S., Orford J.L., Fasseas P., et al. Outcome of patients undergoing balloon angioplasty in the two months prior to noncardiac surgery. Am J Cardiol 96 (2005) 512-514
66. Grines C.L., Bonow R.O., Casey Jr. D.E., et al. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: A science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. J Am Coll Cardiol 49 (2007) 734-739